Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial
| dc.contributor.author | Topkan, Erkan | |
| dc.contributor.author | Somay, Efsun | |
| dc.contributor.author | Selek, Ugur | |
| dc.contributor.author | Pehlivan, Berrin | |
| dc.date.accessioned | 2025-12-23T07:20:05Z | |
| dc.date.issued | 2024-03-29 | |
| dc.identifier.citation | EUROPEAN JOURNAL OF CANCER, cilt 200, 2024 | en |
| dc.identifier.issn | 0959-8049 | |
| dc.identifier.uri | https://hdl.handle.net/11727/14221 | |
| dc.identifier.volume | 200 | en |
| dc.identifier.wos | 001188825600001 | en |
| dc.language.iso | en_US | |
| dc.publisher | Başkent Üniversitesi Diş Hekimliği Fakültesi | |
| dc.source | EUROPEAN JOURNAL OF CANCER | en |
| dc.subject | HEAD | |
| dc.title | Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial | |
| dc.type | Letter |